Xopenex hfa and Poor quality sleep - a phase IV clinical study of FDA data

Summary:

Poor quality sleep is reported as a side effect among people who take Xopenex hfa (levalbuterol tartrate), especially for people who are female, 60+ old, also take Spiriva, and have Narcolepsy.

The phase IV clinical study analyzes which people have Poor quality sleep when taking Xopenex hfa. It is created by eHealthMe based on reports of 2,390 people who have side effects when taking Xopenex hfa from the FDA, and is updated regularly.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

What is Poor quality sleep?

Poor quality sleep is found to be associated with 1,264 drugs and 1,165 conditions by eHealthMe. Check the latest studies of Poor quality sleep.

On Jul, 16, 2026

2,390 people reported to have side effects when taking Xopenex hfa.
Among them, 24 people (1.0%) have Poor quality sleep.

Could Xopenex hfa cause Poor quality sleep?

Among these 24 people:

What is the gender of people who have Poor quality sleep when taking Xopenex hfa? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Poor quality sleep when taking Xopenex hfa? *

What are other drugs people take besides Xopenex hfa? *

What are other side effects people have besides Poor quality sleep? *

Fatigue (feeling of tiredness): 12 people, 50.00%
Pain: 9 people, 37.50%
Pneumonia: 9 people, 37.50%
Headache (pain in head): 8 people, 33.33%
Fever: 8 people, 33.33%
Migraine (headache): 7 people, 29.17%
Weakness: 7 people, 29.17%
Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 29.17%
Upper Respiratory Tract Infection: 7 people, 29.17%
Hypersensitivity: 7 people, 29.17%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 37.50%
Primary Immunodeficiency Syndrome: 6 people, 25.00%
Immunodeficiency Common Variable: 6 people, 25.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 20.83%
Depression: 5 people, 20.83%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.67%
Diabetes: 4 people, 16.67%
Weight Decreased: 4 people, 16.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 16.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex hfa and have Poor quality sleep?

- Check whether Poor quality sleep is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xopenex hfa:

Xopenex hfa (2,529 reports)

Browse all side effects of Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor quality sleep:

Poor quality sleep (1,264 drugs)

Browse all the conditions that are associated with Poor quality sleep:

Poor quality sleep (1,165 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol tartrate (the active ingredients of Xopenex hfa) and Xopenex hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.